A citation-based method for searching scientific literature


List of co-cited articles
38 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy.
Takahisa Hanada, Yutaka Hashizume, Naoki Tokuhara, Osamu Takenaka, Naohiro Kohmura, Aichi Ogasawara, Shinji Hatakeyama, Makoto Ohgoh, Masataka Ueno, Yukio Nishizawa. Epilepsia 2011
245
30

The efficacy of perampanel in young children with drug-resistant epilepsy.
Fu-Man Chang, Pi-Chaun Fan, Wen-Chin Weng, Chin-Hao Chang, Wang-Tso Lee. Seizure 2020
13
20

AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.
Jocelyn J Lippman-Bell, Sanjay N Rakhade, Peter M Klein, Makram Obeid, Michele C Jackson, Annelise Joseph, Frances E Jensen. Epilepsia 2013
44
20


The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Friederike Twele, Marion Bankstahl, Sabine Klein, Kerstin Römermann, Wolfgang Löscher. Neuropharmacology 2015
35
20

Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER).
T Kanda, M Kurokawa, S Tamura, J Nakamura, A Ishii, Y Kuwana, T Serikawa, J Yamada, K Ishihara, M Sasa. Life Sci 1996
58
20

AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
Carlo Di Bonaventura, Angelo Labate, Marta Maschio, Stefano Meletti, Emilio Russo. Expert Opin Pharmacother 2017
35
20

Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
20

Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
Jacqueline A French, Gregory L Krauss, Bernhard J Steinhoff, David Squillacote, Haichen Yang, Dinesh Kumar, Antonio Laurenza. Epilepsia 2013
273
20

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
Pierre Paoletti, Camilla Bellone, Qiang Zhou. Nat Rev Neurosci 2013
20

Topiramate add-on therapy for drug-resistant focal epilepsy.
Rebecca Bresnahan, Juliet Hounsome, Nathalie Jette, Jane L Hutton, Anthony G Marson. Cochrane Database Syst Rev 2019
9
22

Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist.
Rafal M Kaminski, Madhumita Banerjee, Michael A Rogawski. Neuropharmacology 2004
89
20

Topiramate for Treatment in Patients With Migraine and Epilepsy.
Scott D Spritzer, Thomas P Bravo, Joseph F Drazkowski. Headache 2016
18
20

Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
Melissa Barker-Haliski, H Steve White. Cold Spring Harb Perspect Med 2015
158
20


Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures.
Ilse Smolders, Zuner A Bortolotto, Vernon R J Clarke, Ruth Warre, Ghous M Khan, Michael J O'Neill, Paul L Ornstein, David Bleakman, AnnMarie Ogden, Brianne Weiss,[...]. Nat Neurosci 2002
114
20

The role of AMPA receptors and their antagonists in status epilepticus.
Antonio Leo, Giada Giovannini, Emilio Russo, Stefano Meletti. Epilepsia 2018
18
20

Changes in synaptic AMPA receptor concentration and composition in chronic temporal lobe epilepsy.
Daniel L Egbenya, Suleman Hussain, Yi-Chen Lai, Jun Xia, Anne E Anderson, Svend Davanger. Mol Cell Neurosci 2018
21
20

Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis.
Brita Fritsch, Janine Reis, Maciej Gasior, Rafal M Kaminski, Michael A Rogawski. J Neurosci 2014
25
20

Contribution of aberrant GluK2-containing kainate receptors to chronic seizures in temporal lobe epilepsy.
Angélique Peret, Louisa A Christie, David W Ouedraogo, Adam Gorlewicz, Jérôme Epsztein, Christophe Mulle, Valérie Crépel. Cell Rep 2014
39
20

Physiopathology of kainate receptors in epilepsy.
Valérie Crépel, Christophe Mulle. Curr Opin Pharmacol 2015
45
20


AMPA receptors as a molecular target in epilepsy therapy.
M A Rogawski. Acta Neurol Scand Suppl 2013
139
20

The kainic acid model of temporal lobe epilepsy.
Maxime Lévesque, Massimo Avoli. Neurosci Biobehav Rev 2013
268
20

X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor.
Alexander I Sobolevsky, Michael P Rosconi, Eric Gouaux. Nature 2009
718
20


Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus.
Hanan Mohammad, Sathiya Sekar, Zelan Wei, Farzad Moien-Afshari, Changiz Taghibiglou. Mol Neurobiol 2019
18
20

Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice.
C Mulle, A Sailer, I Pérez-Otaño, H Dickinson-Anson, P E Castillo, I Bureau, C Maron, F H Gage, J R Mann, B Bettler,[...]. Nature 1998
379
20

Glutamatergic substrates of drug addiction and alcoholism.
Justin T Gass, M Foster Olive. Biochem Pharmacol 2008
350
20

Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.
Sunil Goodwani, Hannah Saternos, Fawaz Alasmari, Youssef Sari. Neurosci Biobehav Rev 2017
50
20

Metabotropic action of postsynaptic kainate receptors triggers hippocampal long-term potentiation.
Milos M Petrovic, Silvia Viana da Silva, James P Clement, Ladislav Vyklicky, Christophe Mulle, Inmaculada M González-González, Jeremy M Henley. Nat Neurosci 2017
31
20

Kainate receptors coming of age: milestones of two decades of research.
Anis Contractor, Christophe Mulle, Geoffrey T Swanson. Trends Neurosci 2011
177
20

Architecture and subunit arrangement of native AMPA receptors elucidated by cryo-EM.
Yan Zhao, Shanshuang Chen, Adam C Swensen, Wei-Jun Qian, Eric Gouaux. Science 2019
74
20

Synaptic AMPA receptor composition in development, plasticity and disease.
Jeremy M Henley, Kevin A Wilkinson. Nat Rev Neurosci 2016
258
20

Precision medicine and therapies of the future.
Sanjay M Sisodiya. Epilepsia 2021
15
20


Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy.
Song Ee Youn, Se Hee Kim, Ara Ko, Sun Ho Lee, Young Mock Lee, Hoon Chul Kang, Joon Soo Lee, Heung Dong Kim. J Clin Neurol 2018
12
20


A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Kai Gao, Anel Tankovic, Yujia Zhang, Hirofumi Kusumoto, Jin Zhang, Wenjuan Chen, Wenshu XiangWei, Gil H Shaulsky, Chun Hu, Stephen F Traynelis,[...]. PLoS One 2017
35
10

TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists.
Karen Menuz, Robert M Stroud, Roger A Nicoll, Franklin A Hays. Science 2007
113
10


Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.
Asla Pitkänen, Claus Mathiesen, Lars Christian B Rønn, Arne Møller, Jari Nissinen. Epilepsy Res 2007
41
10


Efficacy of felbamate in the treatment of intractable pediatric epilepsy.
Mary L Zupanc, Rhonda Roell Werner, Michael S Schwabe, Sunila E O'Connor, Charles J Marcuccilli, Kurt E Hecox, Maria S Chico, Kathy A Eggener. Pediatr Neurol 2010
19
10

Magnesium gates glutamate-activated channels in mouse central neurones.
L Nowak, P Bregestovski, P Ascher, A Herbet, A Prochiantz. Nature 1984
10


Epilepsy: Novel therapeutic targets.
Ashish P Anovadiya, Jayesh J Sanmukhani, C B Tripathi. J Pharmacol Pharmacother 2012
17
10


Recent developments in the diagnosis and treatment of status epilepticus.
Megan Selvitelli, Frank W Drislane. Curr Neurol Neurosci Rep 2007
4
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.